We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,230
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMP icon
201
Ameriprise Financial
AMP
$48.1B
$1.69M 0.09%
12,102
+1,628
+16% +$231K
WBA
202
DELISTED
Walgreens Boots Alliance
WBA
$1.67M 0.09%
27,835
+27,464
+7,403% +$1.77M
EBAY icon
203
eBay
EBAY
$50.4B
$1.65M 0.09%
45,557
+44,137
+3,108% +$1.72M
DE icon
204
Deere & Co
DE
$162B
$1.64M 0.09%
+11,718
New +$1.73M
BSX icon
205
Boston Scientific
BSX
$68.4B
$1.64M 0.09%
50,033
+47,933
+2,283% +$1.45M
PH icon
206
Parker-Hannifin
PH
$121B
$1.62M 0.09%
10,412
+8,923
+599% +$1.52M
SU icon
207
Suncor Energy
SU
$78.8B
$1.62M 0.09%
39,781
+29,214
+276% +$1.14M
PPH icon
208
VanEck Pharmaceutical ETF
PPH
$970M
$1.61M 0.09%
27,240
+8,860
+48% +$514K
VOX icon
209
Vanguard Communication Services ETF
VOX
$5.52B
$1.6M 0.09%
18,870
-3,629
-16% -$308K
KHC icon
210
Kraft Heinz
KHC
$31.3B
$1.59M 0.09%
+25,388
New +$1.51M
RPV icon
211
Invesco S&P 500 Pure Value ETF
RPV
$1.65B
$1.59M 0.09%
24,198
-6,049
-20% -$401K
UYG icon
212
ProShares Ultra Financials
UYG
$829M
$1.59M 0.09%
39,270
+22,824
+139% +$950K
NVR icon
213
NVR
NVR
$16.8B
$1.56M 0.09%
524
-364
-41% -$1.11M
AFL icon
214
Aflac
AFL
$64.8B
$1.55M 0.09%
36,162
+29,962
+483% +$1.35M
IAT icon
215
iShares US Regional Banks ETF
IAT
$673M
$1.54M 0.09%
31,429
+400
+1% +$20.5K
MSCI icon
216
MSCI
MSCI
$41.9B
$1.54M 0.09%
9,315
-371
-4% -$58.5K
ETN icon
217
Eaton
ETN
$150B
$1.54M 0.09%
20,610
+18,110
+724% +$1.4M
PSQ icon
218
ProShares Short QQQ
PSQ
$829M
$1.53M 0.09%
9,630
+2,523
+36% +$412K
ALXN
219
DELISTED
Alexion Pharmaceuticals
ALXN
$1.53M 0.09%
12,315
+11,984
+3,621% +$1.4M
FISV
220
Fiserv Inc
FISV
$28.8B
$1.52M 0.09%
20,497
+20,428
+29,606% +$1.48M
CBRE icon
221
CBRE Group
CBRE
$43.3B
$1.52M 0.09%
+31,789
New +$1.5M
URTY icon
222
ProShares UltraPro Russell2000
URTY
$327M
$1.52M 0.09%
15,699
+12,354
+369% +$1.13M
TSS
223
DELISTED
Total System Services, Inc.
TSS
$1.51M 0.08%
+17,919
New +$1.54M
ARE icon
224
Alexandria Real Estate Equities
ARE
$9.15B
$1.51M 0.08%
+12,001
New +$1.5M
ORLY icon
225
O'Reilly Automotive
ORLY
$71.3B
$1.51M 0.08%
+82,875
New +$1.44M

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,230 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,230 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.